The Delaware Supreme Court on Tuesday threw out a biopharmaceutical company's $82 million jury trial win in a suit alleging Express Scripts Inc. fraudulently skewed its revenues to close a multimillion-dollar acquisition, ruling the trial court gave jurors an "erroneous" instruction and a new trial is warranted.